Prophylaxis and treatment of venous thrombosis, pulmonary embolism, and thromboembolic disorders in connection with certain fibrillations, mitral valvulopathies, valvular prosthesis, myocardial infarctions, hip surgery, or catheter placement
Adults: Oral: Initial: 20 mg once daily; maintenance: Adjust according to coagulation (INR) monitoring
Product available in various countries; not currently available in the US
Tablet: 20 mg
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟